Trajan Group Holdings Ltd (AU:TRJ) has released an update.
Trajan Group Holdings Ltd faced challenges in the first half of the year due to industry-wide de-stocking but saw a strong rebound in the second half, demonstrating resilience and strength. Despite falling short of initial expectations, the company achieved nearly 5% of its revenue target and more than a 50% increase in EBITDA. With a focus on science-driven personalized healthcare, Trajan remains optimistic about future growth and shareholder value.
For further insights into AU:TRJ stock, check out TipRanks’ Stock Analysis page.